Clinical Trial Update: Phase I Pediatric FMP2.1/AS02A Trial in Mali [Phase 1]

View source ↗

Summary

A Phase I pediatric trial of the malaria vaccine candidate FMP2.1/AS02A conducted in Mali has completed, with results posted in March 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• FMP2.1/AS02A

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Plasmodium Falciparum Malaria | Phase 1 | Status: COMPLETED | Results posted: 2009-03-04